Bottneuro

Bottneuro AG, founded in 2021, is a cutting-edge medical technology startup focused on improving the diagnosis and treatment of neurological disorders. Bottneuro develops digital therapeutics for Alzheimer's disease by electrically stimulating glial cells in the brain.